FEATURE ARTICLES FROM THIS WEEK |
|
|
Cleveland Clinic Pledges $50 Million to Address Hunger
Cleveland Clinic President and CEO Tom Mihaljevic, M.D., with Greater Cleveland Food Bank President & CEO Kristin Warzocha in 2023. Courtesy of Cleveland Clinic
Multi-year funding will strengthen community infrastructure that helps families access nutritious food
February 27, 2026- Cleveland Clinic has made a five year, $50 million commitment to reduce hunger and improve access to nutritious food across Ohio, Florida and Nevada through direct support to local food banks and community-based organizations that are providing food to those in need.
This long term investment is designed to give community organizations the stability they need to continue their critical work. By providing essential funding over five years, the pledge helps strengthen the local systems that ensure families have reliable access to nutritious food. The commitment offers partners the security to plan for the future, expand proven programs and build lasting capacity within the communities they serve.
“Our success fuels our responsibility. As an anchor institution, Cleveland Clinic has a duty to reinvest in the communities we serve,” said Tom Mihaljevic, M.D., Cleveland Clinic President and CEO, and holder of the Morton Mandel CEO Chair at Cleveland Clinic. “Expanding access to nutritious food is one of the most powerful ways we can support health, stability and opportunity for families.
READ MORE |
|
Baptist Health Foundation Hosts an Evening of Gratitude Benefiting Bethesda Hospital
February 27, 2026 – More than 150 guests attended the Evening of Gratitude benefiting Bethesda Hospital, part of Baptist Health, which was held on Friday, February 20 at the OPAL Grand Resort & Spa in Delray Beach. Presented by Barbara and Ben Lucas and Pam and Michael McCarthy, the event honored members of Baptist Health Foundation’s Giving Society and other donors to Bethesda Hospital.
The Bethesda Hospital Evening of Gratitude raised over $650,000 to support the advancement of cardiac care at the hospital. The event featured a cocktail hour, seated dinner and live entertainment. Speakers included Jared Smith, CEO of Bethesda Hospital and honorary event chair; Barbara James, VP of Baptist Health Foundation; and Bradley Taylor, M.D., chief of cardiac surgery, North Region.
“At Bethesda Hospital, we are dedicated to excellence in every respect – from our caring employees and highly skilled physicians to the latest medical technology,” said Mr. Smith. “We’re grateful to our donors for their continued support, and look forward to the progress ahead as we continue enhancing care for our community.”
Added Dr. Taylor, “Philanthropic support helped make our hybrid OR possible and brought the TAVR procedure — a nonsurgical procedure to replace the heart’s aortic valve — to our patients. With continued donor support, we’ll be able to expand innovative cardiac treatments and improve outcomes for even more families in our community.”
READ MORE |
|
|
UPCOMING NETWORKING MEETINGS AND EDUCATIONAL WEBINARS |
|
|
1.5 ACHE In-Person Education Credits
Tuesday, March 10, 2026
Time: Breakfast and Registration 7:30am
Program Begins: 8:00am
CLICK HERE TO REGISTER |
| |
|
CLICK HERE TO REGISTER FOR THIS "AI EXECUTIVE WORKSHOP" THIS IS A SPECIAL OFFER TO OUR READSERSHI, IF YOU CLICK ON THE EMAIL BELOW, WE WILL SEND YOU A DISCOUNT CODE FOR REGISTRATION. THIS OFFER IS LIMITED TO THE FIRST 30 WHO EMAIL US AND REGISTER FOR THE EVENT.
charles@southfloridahospitalnews.com |
| |
|
SUBMIT YOUR PROFILES, ARTICLES AND ADS BY FOR OUR ANNUAL SALUTE TO DOCTORS |
|
|
UPDATED NEWS INFORMATION FROM THE LAST FOUR DAYS IN SOUTH FLORIDA |
Cleveland Clinic Ranked No. 3 Hospital in the World by Newsweek
Cleveland Clinic Abu Dhabi, Cleveland Clinic Fairview and Cleveland Clinic Weston Hospital also rank among the Top 250 hospitals in the world
Feb. 26, 2026 – Cleveland Clinic is the No. 3 hospital in the world, according to Newsweek’s World’s Best Hospitals 2026.
Cleveland Clinic Abu Dhabi (No. 119), Cleveland Clinic Fairview Hospital (No. 228) and Cleveland Clinic Weston Hospital (No. 246) are also recognized among the Top 250 hospitals in the world.
“Our model has endured for generations – a global team, centered around the patient, impacting as many lives as possible,” said Cleveland Clinic CEO and President Tom Mihaljevic, M.D., holder of the Morton L. Mandel CEO Chair at Cleveland Clinic. “What makes Cleveland Clinic different is our caregivers’ dedication to our mission. Together, we choose to be there for others in their time of need, with compassion, dignity and service.”
In addition to the worldwide rankings, seven Cleveland Clinic hospitals are included in Newsweek’s best hospitals in the United States:
Cleveland Clinic (No. 2)
Cleveland Clinic Fairview Hospital (No. 36)
Cleveland Clinic Weston Hospital (No. 40)
Cleveland Clinic Akron General (No. 83)
Cleveland Clinic Hillcrest Hospital (No. 111)
Cleveland Clinic Avon Hospital (No. 233)
Cleveland Clinic Marymount Hospital (No. 415)
Cleveland Clinic Abu Dhabi is ranked the No. 1 hospital in the UAE.
According to Newsweek, each hospital was reviewed and given a score based on four data sources: recommendations from medical experts – including doctors, hospital managers and other health care professionals – hospital quality metrics, existing patient experience data and Statista’s Patient-Reported Outcome Measures Implementation Survey.
READ MORE |
Tampa General Hospital and Florida Orthopaedic Institute Perform Florida’s First TOUCH CMC Prosthesis Surgery, Advancing Care for Thumb Arthritis
The only FDA-approved implant for total thumb joint replacement offers patients improved mobility, strength and lasting pain relief.
February 26, 2026 – In a significant breakthrough for hand surgery and joint replacement, Tampa General Hospital (TGH) and the Florida Orthopaedic Institute (FOI) have become the first in Florida to perform surgery using the TOUCH CMC prosthesis, an innovative artificial joint designed to treat thumb carpometacarpal (CMC) osteoarthritis. This debilitating condition affects millions of Americans and can severely impair hand function and quality of life.
The TOUCH CMC prosthesis is the first implant of its kind to gain Food and Drug Administration (FDA) approval in the United States for total joint replacement of the first CMC joint. The prosthesis provides a groundbreaking option for patients with moderate to severe thumb arthritis seeking improved mobility, strength and pain relief after nonsurgical treatments have failed.
“This procedure, performed by Dr. Devin Collins and Dr. Alfred Hess of Florida Orthopaedic Institute, represents a major step forward in restoring hand function and improving quality of life for patients,” said Dr. Roy Sanders, Chief, TGH Orthopaedic Institute and Orthopaedic Surgery, Professor & Chair, Department of Orthopaedic Surgery USF Health Morsani College of Medicine, President & Chief Medical Officer Florida Orthopaedic Institute. “Introducing this next-generation surgical implant as the first in the state underscores our unwavering commitment to clinical excellence and our mission to deliver the best of modern medicine — driven by evidence, powered by innovation and centered on the patient.”
Currently in limited market release, the TOUCH CMC prosthesis has been used in 20 facilities across the country. Florida Orthopaedic Institute was chosen as a key launch site because of its national reputation for clinical leadership and its longstanding fellowship program.
READ MORE | Cleveland Clinic Florida Receives $3 Million Gift to Establish Endowed Chair in Cardiovascular Medicine
February 26, 2026 — Cleveland Clinic has established the Eric and Lois Zorn Endowed Chair in Cardiovascular Medicine, supported by a $3 million philanthropic gift from Eric and Lois Zorn.
The endowed chair recognizes Jerry Estep, M.D., division chair of Cardiovascular Medicine for Cleveland Clinic Florida, and will support continued advancement in patient care, research and education. Dr. Estep has been named the inaugural holder of the endowed chair and leads cardiovascular medicine across Cleveland Clinic Florida, with an emphasis on coordinated, patient-centered care and innovation in the prevention and treatment of cardiovascular disease.
The Zorns’ gift was inspired by years of care Eric Zorn has received at Cleveland Clinic, including treatment for cardiac amyloidosis, a rare protein disorder affecting the heart, as well as more recent life-threatening acute renal failure. Zorn’s cardiovascular journey began after he developed worsening symptoms while playing golf near his home in Sarasota, Florida. He later underwent quadruple bypass surgery at another hospital, followed by a rapid decline in his health, until Cleveland Clinic specialists identified amyloidosis as the underlying cause of his heart failure and initiated treatment.
READ MORE |
Broward Health Medical Center Hosts Lung Cancer Awareness Event with Interactive Robotic Experience
Premedical students from American Heritage High School
Broward Health Medical Center hosted a free, interactive lung cancer awareness event focused on early detection and diagnosis, featuring the ION robotic bronchoscopy system.
Premedical students from American Heritage High School and fifth graders from Christian Life Academy gained hands-on experience with the technology.
The Ion robotic bronchoscopy system was housed inside the Thoracic Oncology Mobile Experience, or TOME truck, an 18-wheel, 80,000-pound interactive laboratory designed to bring advanced robotic systems and instruments to hospitals nationwide.
READ MORE |
Study: Exercise During Chemotherapy for Breast Cancer Measurably Improves Quality of Life
“This work helps move exercise from the margins into the mainstream of oncology care,” said Tracy Crane, Ph.D., RDN, study co-author. “It shows that any form of exercise during chemotherapy has a positive impact on quality of life for women being treated for breast cancer.”
Exercise as a form of supportive care is not about changing cancer treatment — it’s about improving how patients live through it.
February . 25, 2026 – For many women with breast cancer, the very treatment that saves their lives can also bring fatigue, loss of muscle mass, emotional strain and other daunting obstacles. A new study shows that exercise during chemotherapy does more than rebuild strength — it measurably improves quality of life while treatment is underway, helping women feel better physically, emotionally and mentally during one of the most demanding chapters of care.
Led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, the findings come from a large meta-analysis published in The Lancet Healthy Longevity and synthesize results from more than two dozen studies of women receiving chemotherapy for breast cancer.
Modern breast cancer treatment has dramatically improved survival rates. But alongside those gains, clinicians and researchers are increasingly focused on how patients feel during treatment — their energy, mood, mobility and sense of well-being.
“Chemotherapy places stress on every system in the body,” said LaShae D. Rolle, MPH, CPH, lead author of the study, a predoctoral fellow conducting research at Sylvester. “Quality of life becomes a central outcome during treatment, not something to consider only after it ends.”
READ MORE |
Alanna Sholomon, D.O., Joins Baptist Health Primary Care
February 26, 2026 – Board-certified internal medicine physician Alanna Sholomon, D.O., has joined Baptist Health Primary Care. She has more than 15 years of experience providing patients with comprehensive preventive care and treating a wide range of acute and chronic health conditions in various primary care settings.
Prior to joining Baptist Health, Dr. Sholomon was an internal medicine physician at Boro Park Medical PC in Brooklyn, N.Y.
“We are happy to welcome Dr. Sholomon to our team of skilled medical professionals, who are committed to partnering with our patients to provide consistent, comprehensive care for all stages of life,” said Marcella Gravalese, MBA-HSA, vice president of Baptist Health Medical Group North.
Dr. Sholomon earned her medical degree at the New York College of Osteopathic Medicine and completed an internal medicine residency at Maimonides Medical Center in Brooklyn, N.Y.
READ MORE |
Florida Pediatricians Advocate for Children’s Health at Children’s Week 2026
Pediatricians Speak Out Against Bill to Expand Non-Medical Vaccine Exemptions
February 26, 2026- Tallahassee, Florida – Pediatricians from across the state gathered in Tallahassee this week to participate in the 2026 Children’s Week and Children’s Capitol for a Day events, and to remind Florida’s legislators to keep the health of Florida’s children at the top of their minds when considering legislation.
Each year, members of the Florida Chapter of American Academy of Pediatrics (“FCAAP”) travel to Tallahassee to talk with families, lawmakers, educators, and other stakeholders about the issues impacting children’s health in the state. This year, the event coincided with a Senate Appropriations Committee hearing about a bill that would expand non-medical vaccine exemptions, and pediatricians voiced their opposition to it.
Pediatricians from every corner of the state shared with policymakers the dangers of expanding non-medical vaccine exemptions to Florida’s longstanding school entry requirements. Florida’s kindergarten vaccination rate of less than 89 percent is significantly below the 95 percent threshold needed to achieve widespread community immunity from the most infectious diseases. Adding additional non-medical exemptions to school vaccine requirements risks the return of dangerous and preventable diseases like measles, polio, and whooping cough.
READ MORE |
Study measuring changes in protein structure establishes new class of Alzheimer’s biomarkers
NIH-funded insights into Alzheimer’s biology could help with early diagnosis, future clinical trials.
February 27, 2026 – In a study supported by the National Institutes of Health (NIH), researchers have identified a new type of blood-based biomarker test for Alzheimer’s disease that measures structural changes in proteins, providing more information on the underlying biology of the disease than standard blood tests. The findings, published in Nature Aging, also provide new insights into how Alzheimer’s disease biology may differ between males and females.
“This work introduces a fundamentally new, blood-based approach to detecting and staging Alzheimer’s disease,” said Dr. Richard Hodes, director of NIH’s National Institute on Aging (NIA), which funded the study. “By revealing protein structural changes associated with genetic risk, symptom severity, and sex differences—features not captured by existing biomarkers—this research could enable earlier diagnosis and more effective clinical trials.”
Most Alzheimer’s blood tests measure how much of an Alzheimer’s-linked protein is present. However, it is known that in Alzheimer’s disease, breakdown of the regulation of cell function causes protein misfolding. The researchers in this study wanted to know whether these structural changes could be identified in blood tests to detect the disease. They hypothesized that comprehensive investigation of structural changes in Alzheimer’s-associated proteins could reveal more about the mechanisms underlying disease risk factors and symptoms than current blood tests and could potentially identify additional blood-based biomarkers for the disease.
In addition, almost all individuals with Alzheimer’s develop neuropsychiatric symptoms, but research suggests differences between males and females in the frequency and severity of certain symptoms. The authors of this study wondered whether structural changes in proteins could help researchers better understand the biological processes underlying these sex differences.
READ MORE |
HCA Healthcare Named a World’s Most Admired Company by Fortune for the 12th Consecutive Year
February 26, 2026 – HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has been named on Fortune’s 2026 World’s Most Admired Companies list. HCA Healthcare is ranked No. 1 in its industry again this year.
“We are proud to again be recognized on Fortune’s World’s Most Admired Companies list,” said Sam Hazen, CEO of HCA Healthcare. “I am grateful to our colleagues for the way they lead with compassion and the high standards they set across the organization as we work to improve outcomes and experiences for patients.”
Since 1997, Fortune has collaborated with Korn Ferry to determine the World’s Most Admired Companies list. This year 685 companies across 51 industries and 29 countries were analyzed. The top-rated companies were rated by executives, directors and analysts on nine criteria: innovation, people management, use of corporate assets, social responsibility, quality of management, financial soundness, long-term investment, quality of products and services, and global competitiveness.
HCA Healthcare strives to elevate the delivery of care through research and innovation. In 2025, HCA Healthcare Research Institute, the multispecialty clinical research arm of the company, grew to 54 sites across the country and enrolled more than 6,600 patients in more than 520 active research studies. HCA Healthcare’s Digital Transformation & Innovation department also continues to build upon technology platform investments to help improve patient outcomes, increase efficiency, strengthen the connection of the company’s care networks and create more time for what matters most: caring for patients.
READ MORE |
Universal Health Services Announces New Patriot Support Programs Advisory Board Member
February 26, 2026 — Universal Health Services (NYSE: UHS) is pleased to announce that Chief Master Sergeant (Ret) Dawn M. Kolczynski has joined the Patriot Support Programs Advisory Board, further strengthening the board’s leadership with her extensive military healthcare expertise.
At subsidiary behavioral health facilities across the country designated as Patriot Support Program entities, UHS provides treatment for active-duty military, veterans and their families. Programs and services are specifically designed to address the effects of combat stress, post-traumatic stress, depression, substance use disorder and other behavioral health issues.
Chief Master Sergeant Kolczynski brings a wealth of experience from her diverse career, previously serving as the Senior Enlisted Leader, Operations, Plans and Training (J-3/5/7) for the Defense Health Agency (DHA) where she provided oversight and guidance for integrating military and civilian healthcare delivery across the Military Health System. Her efforts ensured DHA operational support to military hospitals and clinics, combatant commands, the Joint Staff, and the military services to guarantee a medically ready force and a ready medical force.
Additionally, Chief Master Sergeant Kolczynski completed a four-year assignment with NATO as the Superintendent of the Safety and Health Branch and was the Chief of Medical Enlisted Forces at Office of the Air Force Surgeon General.
“UHS is honored to serve active-duty military personnel, veterans and family members, including through our Patriot Support Programs,” said Matt Peterson, Executive Vice President and President, UHS Behavioral Health Division. “With Chief Master Sergeant Kolczynski’s deep military health system expertise and leadership, alongside our distinguished Advisory Board members, we will continue enhancing our support to ensure our military communities receive the highest quality care. I look forward to the invaluable guidance she will bring.”
READ MORE |
Study identifies potential immunotherapy strategy for early-stage prostate cancer
February 27, 2026 – A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically “cold,” meaning they do not attract enough immune cells to mount a strong attack. Hormone therapy commonly used for prostate cancer, called androgen deprivation therapy (ADT), can temporarily make tumors more responsive by drawing immune cells into the cancer. But that benefit is short-lived: the treatment also increases levels of regulatory T cells (Tregs), which act as brakes on the immune system and blunt its anti-cancer effects.
In the first-in-human, early-phase randomized trial, researchers tested whether adding a next-generation immunotherapy to hormone therapy before surgery could counteract that immune-suppression. The combination reduced Treg levels inside prostate tumors. Patients whose tumors showed the greatest reductions were more likely to remain cancer-free during follow-up.
“This trial provided a unique opportunity to test a new immunotherapy drug in patients who have localized prostate cancer. They don’t have metastatic disease yet, but they are at high risk of reaching that stage. These are patients who possibly can be cured,” says Casey Ager, Ph.D., a cancer immunology researcher at Mayo Clinic and first author of the study.
ADT starves cancer cells of male hormones like testosterone, which they use as fuel. Desirable immune effects of ADT are cut short by Tregs, which normally keep the immune system from overreacting to substances and attacking the body. In the case of prostate cancer, Dr. Ager says they limit immunotherapy effectiveness.
“Hormonal therapy brings many types of immune cells in that can attack and kill the tumor. But this comes with an equal and opposite reaction where Tregs also come in and suppress the immune system, allowing the tumor to ultimately progress,” says Dr. Ager. He and a team of Mayo Clinic researchers collaborated with colleagues at Columbia University Irving Medical Center, Memorial Sloan Kettering Cancer Center and Bristol Myers Squibb to investigate whether suppressing Tregs could overcome this hurdle by safely releasing the immune system’s “brakes” to help it mount a better response against prostate cancer.
READ MORE |
Secretary Kennedy Appoints Two Physicians to CDC’s Advisory Committee on Immunization Practices
FEB. 27, 2026 — The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) today announced the appointment of two new members to the CDC Advisory Committee on Immunization Practices (ACIP). These appointments reflect the commitment of Health and Human Services Secretary Robert F. Kennedy, Jr. to transparency, rigorous science, and diverse clinical expertise in guiding the nation’s immunization policies. In June 2025, Secretary Kennedy reconstituted ACIP to restore public trust in vaccines.
The two new members are:
Sean G. Downing, M.D., physician specializing in Internal Medicine and Pediatrics. Dr. Downing is a Florida-licensed physician who has practiced primary care across the lifespan for more than two decades, including internal medicine and pediatric concierge care in Sarasota, Florida, with admission privileges at Sarasota Memorial Hospital. He previously served as an outpatient primary care physician for medically uninsured patients in Nashua, New Hampshire, and also worked part-time in emergency/urgent care settings. Dr. Downing completed a combined Internal Medicine and Pediatrics residency at Brown University and earned his M.D. from Georgetown University School of Medicine, with additional graduate training in physiology and pharmacology.
Angelina Farella, M.D., pediatrician and owner of A Brighter Tomorrow Family Health and Wellness in Webster, Texas. Dr. Farella has practiced pediatric care for more than two decades, including leading her own practice since 2004 and serving in a range of clinical roles spanning private practice, pediatric urgent care, and locum tenens work. She completed pediatric residency training at the University of Texas Medical Branch (UTMB), including service as Pediatric Chief Resident, and held academic appointments including Clinical Assistant Professor at UTMB and Adjunct Clinical Professor at William Carey University College of Osteopathic Medicine. Dr. Farella earned her M.D. with honors from Ross University School of Medicine and her B.A. in Biology from Rutgers University.
“ACIP must scrutinize the evidence openly, ask hard questions, and earn the nation’s confidence through transparent deliberation,” Secretary Kennedy said. “Dr. Downing and Dr. Farella bring decades of real-world experience caring for children, adults, and families—and that frontline perspective is essential to making recommendations that are grounded in gold-standard science and worthy of public trust.”
READ MORE |
HHS, USDA, and EPA Announce Over $1B in Investments and Plan to Accelerate Progress on Farm Modernization and Long-Term Food Supply Security
February 27, 2026 – Background:
The Executive Order (14212) establishing the MAHA Commission directed the involved agencies to work with farmers to ensure that United States food is the healthiest, most abundant, and most affordable in the world. American farmers are critical partners in the success of the Make America Healthy Again agenda. President Trump’s recent executive order regarding elemental phosphorus and glyphosate is focused on ensuring national and food supply security by guaranteeing an adequate domestic supply of these materials on which our agricultural industry currently relies. This plan and these investments show that the federal government also recognizes the need to accelerate farm modernization and long-term food supply security.
Three-Pillar Plan to Accelerate Progress:
Better understand risks of chemicals to individual and population health
Increase federal government investment in regenerative agriculture practices and education
Spur private sector innovation in farming modernization by reducing red tape and matching private funding
Research Focus:
The Environmental Protection Agency (EPA), U.S. Department of Agriculture (USDA), and National Institutes for Health (NIH) will develop a research and evaluation framework for cumulative exposure across chemical classes in the food supply. This research will focus on using and developing New Approach Methodologies to overcome prior barriers to fully understanding human health and environmental risks of chemical contaminants, and addressing these risks for even greater food security and safety.
READ MORE |
OFFICIAL SPONSOR OF LEADERSHIP INTERVIEWS |
EXCLUSIVE HOSPITAL LEADERSHIP INTERVIEWS BY
SOUTH FLORIDA HOSPITAL NEWS & HEALTHCARE REPORT |
Interview with Brent Lucas, CEO of Envoy Medical, Inc. CLICK HERE Interview with Dr. Rachel Docekal, CEO of The Hanley Foundation CLICK HERE
Interview with John D. Couris who is President and CEO of Florida Health Sciences Center and Tampa General Hospital CLICK HERE Interview with Shane Strum President/CEO of Broward Health by Charles Felix from South Florida Hospital News and Healthcare Report - February 2023
CLICK HERE
Interview with Matthew Garner CEO of Broward Health North by Charles Felix from South Florida Hospital News and Healthcare Report in February 2023.
CLICK HERE
See More Interviews - Click Here |
CLICK ON THE IMAGE ABOVE TO EXPLORE ACHA DATA IN FLORIDA.
DATA FROM 2016 TO 2024 IS AVAILABLE.
CLICK HERE TO SAMPLE THIS DATA FOR MORE INFORMATION CALL CHARLES FELIX AT 954-605-4785. |
Please Like Us on FaceBook by clicking on the FaceBook Logo.
Thank you |
| UPCOMING MEETINGS & EVENTS AND MARKETING OPPORTUNITIES
|
MARKETING AND PUBLIC RELATIONS CAMPAIGNS SHOULD BE USING THE RESOURCES OF SFHN&HR
Start the year with a comprehensive print and digital marketing program.
NOW ACCEPTING
ARTICLES AND ADS FOR THE
APRIL 2026
“Annual Salute to Volunteers” Healthcare Volunteerism in South Florida Healthcare Consulting/ Outsourcing Insurance for Healthcare Professionals, Business and Consumers National Minority Health Month
Organ and Tissue Donation Awareness Stress Awareness Month Selling and Buying Medical Practices
“CALL TODAY TO ARRANGE A STRATEGIC MARKETING MEETING
FOR 2026”
DISCOUNTED BUNDLED PRINT AND DIGITAL MESSAGING PROGRAMS Call today to find out how to qualify for a FREE Company Bio with any size ad. Call me today to discuss editorial and advertising 954-605-4785 |
PLAN YOUR 2026 ANNUAL SALUTES TO YOUR HEALTHCARE PROFESSIONALS
April – Salute to Healthcare Volunteers May – Salute to Nurses
June – Salute to Emergency Department July – Salute to Financial Directors and Managers
August – Salute to Leadership September - Salute to Mental Health Therapists
October – Salute to Case Management November – Salute to Hospice and Palliative Care November - Salute to IT Directors and Managers The pricing for ads in these issues are discounted by 40%. |
Upcoming Healthcare
Events are Listed Below |
UHealth Cardiac Surgery Team Expands, Advances Innovative Care In the heart of South Florida’s cardiac-care landscape, UHealth – University of Miami Health System’s Cardiac Surgery team is launching a bold new era. With Dr. Juan Pablo Umaña as Chief of Cardiothoracic Surgery, the program gains a globally recognized surgeon whose pioneering work in aortic and mitral valve repair—including co-inventing the MitraClip™ and building Latin America’s largest program—sets the stage for innovation. Dr. Ciro Amodio adds deep expertise in complex aortic, thoracoabdominal, and endovascular surgeries, including hybrid “frozen elephant trunk” operations and valve-sparing approaches. With his global training and experience, he enhances care for the most challenging cardiac patients.
Together, they’re transforming UHealth into a fully integrated hub of cardiovascular excellence—advancing minimally invasive heart techniques, expanding aortic surgery, and elevating training. Patients across Florida and beyond now have access to world-class treatments close to home. May 2026 |
Discover Emerging Immunotherapies for Hematologic Malignancies
Immunotherapy for treatment of hematologic malignancies is an ever-evolving multidisciplinary field. At the Seventh Annual Global Summit on Immunotherapies for Hematologic Malignancies on March 6-7, Baptist Health Miami Cancer Institute will bring together researchers and physicians to share the latest innovations and advancements in immunotherapy for leukemias, lymphomas and multiple myeloma. “Our 2026 Summit is designed to convene leading experts and practitioners to review best practices, novel therapeutic strategies and the latest data, all to help improve outcomes for patients with hematologic malignancies,” said Guenther Koehne, M.D., Ph.D., Founder of the Summit, Deputy Director of Miami Cancer Institute and Chief of Stem Cell Transplantation & Hematologic Oncology. The two-day symposium features expert-led sessions, case reviews and interactive panels where attendees will gain valuable knowledge to tackle real-world challenges in treating hematologic cancers.
Register to reserve your spot today. 3/6/26 |
Tampa General Hospital Cancer Institute and USF Health Morsani College of Medicine to Host International Cancer Research Leaders for the “Microbes, Genes & Cancer” Symposium
The conference will be held in Tampa, Florida, at the USF Health Morsani College of Medicine in downtown, in the heart of the Tampa Research and Medical District. Set for March 2-3, 2026, conference will bring to Tampa internationally recognized experts from several scientific cancer-related disciplines.
January 27, 2026 – The Tampa General Hospital (TGH) Cancer Institute and the USF Health Morsani College of Medicine will host leading cancer researchers, clinicians and translational scientists from across the U.S. and around the world March 2-3, 2026, in Tampa, Florida, for the “Microbes, Genes & Cancer” Symposium. This multidisciplinary, scientific conference will examine how microbes, genetics/epigenetics and immune pathways intersect to drive cancer development, progression, and treatment response.
READ MORE |
Healthcare Webinar Alert from OneZero Solutions
Join us on March 3rd at 1 PM ET for a focused executive briefing on the proposed HIPAA Privacy and Security Rule updates and what they mean for healthcare leaders.
Proposed updates to the HIPAA Privacy Rule and the most significant changes to the HIPAA Security Rule in over a decade are expected to materially impact patient access workflows, encryption standards, incident response planning, risk analysis documentation, and executive accountability.
This executive briefing will provide healthcare leaders and business associates with a practical roadmap for preparing now.
In this session, you will learn:
• What is changing in the HIPAA Privacy Rule and how it affects patient access and Notice of Privacy Practices
• How proposed Security Rule updates shift expectations around encryption, multi-factor authentication, and vulnerability management
• What increased enforcement means for breach notification and incident response readiness
• How to align privacy governance and cybersecurity into a unified compliance strategy
• What executives should be planning, budgeting, and documenting before these changes take effect
READ MORE |
Join us for our 2026 Summer Conference, Advancing Patient Care: Optimization through innovation and collaboration, taking place June 26–27, 2026, at Disney’s Coronado Springs Resort. This dynamic two-half day event will bring together thought leaders and frontline professionals to explore innovative strategies, the implementation of new technology, and collaborative models that are contributing to improved patient care
To view the conference agenda, please click here. Whether you are advancing clinical outcomes, building workforce pipelines, or strengthening organizational culture, this conference will offer valuable takeaways for every role across the care continuum. Secure your spot today and be part of the conversation driving nursing forward. Click here to register now!
|
LIVE WEBCAST
Driving Innovation in Healthcare Technology: The Impacts of OB3 Tuesday, April 7, 2026 12:00 – 1:00 PM ET
Explore the impact of the One Big, Beautiful Bill (OB3), offering strategic insights and technology solutions for modernizing legacy systems and implementing unified billing to drive efficiency, transparency, and improved patient and payer experiences. Key Highlights:
Analyze the operational implications of the One Big, Beautiful Bill (OB3) and identify key challenges and opportunities it presents for healthcare organizations and payers. Explore strategic approaches and technology solutions for modernizing legacy systems to enhance agility, scalability, and performance in a rapidly evolving healthcare environment. Evaluate the role of unified billing platforms in streamlining revenue cycle operations, improving transparency, and supporting integrated care delivery under OB3-driven initiatives.
This is a non-CPE webcast.
|
.FOR ADDITIONAL INFORMATION ABOUT FUTURE EVENTS
CLICK HERE |
CALL CHARLES FELIX TO ADVERTISE YOUR JOB OPENINGS - 954-605-4785 STARTING AS LOW AS $50 |
FEBRUARY 25, 2026
READ THE CURRENT NEWSLETTER FROM
CANNABIS NEWS FLORIDA |
Over 932,000
Patients in Florida are using Cannabis as their Medicine FOR LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA HERE
Highlights from
FEBRUARY 27, 2026 BY THE NUMBERS Qualified Patients: (Active ID Card) Feb 27 2026- 933,355 Feb 20 2026- 932,890
Feb 13 2026- 932,702 Feb 06 2026- 932,591 Jan 30 2026- 932,747
Jan 23 2026- 932,407
Patients Added Last Week: +465 Qualified Ordering Physicians:
2,181
New Doctors added Last Week: -11
Reporting Period: FEB 20 - FEB 26 2026
Amount of Medical Marijuana Dispensed - (mgs THC) 446,153,927
Amount of Low-THC Cannabis Dispensed - (mgs CBD ) 0
Amount of Marijuana in a Form for Smoking (oz) 145,900.467 Approved Dispensing Locations: 742 Added Last Week: 1
Goldflower Cannabis - Summerfield |
|
|
RECENT EDUCATION SEMINARS HOSTED BY THE
SOUTH FLORIDA HOSPITAL NEWS NETWORK DISABILITY INSURANCE EDUCATION WEBINAR Understanding the Disability Insurance Market in Florida with Howard Wolkowitz and Michael Tyler.
June 27, 2024
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law How Experienced Physicians Protect their Assets. May 21, 2024
CLICK HERE TO VIEW VIDEO
Presented by Dabdoub Law Firm PHYSICIAN DISABILITY INSURANCE WEBINAR – TIMING IS EVERYTHING – PART 2
MAY 21, 2024
CLICK HERE TO VIEW VIDEO Presented by Mirza Healthcare Law How to start your Healthcare Practice? March 19, 2024
CLICK HERE TO VIEW VIDEO Presented by Coleman Consulting Physician Practice Management - Managing Pit Falls in your Practice - Recorded on Feb 13, 2024.
CLICK HERE TO VIEW VIDEO Presented by Dabdoub Law Firm PHYSICIAN DISABILITY INSURANCE WEBINAR – WHAT YOU NEED TO KNOW – PART 1
CLICK HERE TO VIEW VIDEO Presented by Mirza Healthcare Law "HOW TO HANDLE COLLECTION CHALLENGES OF WORKING WITH HEALTH PLANS"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "How Experienced Physicians Protect their Assets"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "How to Minimize the Risk of Malpractice Lawsuits"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "So, I Signed a Non-Compete, Now What?"
CLICK HERE TO VIEW VIDEO Presented by Mirza Healthcare Law "How to Approach and Do Business With Large Healthcare Systems"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "How Mergers & Acquisitions in Healthcare are Done!"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "How to Navigate - Hospital Medical Executive Committees, Peer Reviews, Investigations, and Bylaws"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "How Experienced Physicians Negotiate Employment Agreements"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law “ASSESSING LIABILITY RISKS: HOW TO PROTECT YOUR PROFESSIONAL PRACTICE AND REPUTATION”
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law "So, I Signed a Non-Compete, Now What?"
CLICK HERE TO VIEW VIDEO
Presented by Mirza Healthcare Law Stark Law - How can Physicians and Hospitals Avoid Problems and Still Work Together
CLICK HERE TO VIEW VIDEO
CLICK HERE VIEW ADDITIONAL WEBINARS |
|
|
|